About 10 results found for searched term "59-23-4" (0.064 seconds)
Cat.No. | Name | Target |
---|---|---|
M6103 | Cetuximab | EGFR/HER2 |
C225;Erbitux | ||
Cetuximab is a chimeric IgG1 monoclonal antibody to EGFR that inhibits the interaction of EGFR with its ligand. For use in cellular assays, human IgG antibody can be used as an isotype control. (For human and non-humanized mice). | ||
M7148 | PNU 22394 hydrochloride | Others |
PNU 22394 hydrochloride is a 5-HT 2C agonist and 5-HT 2A/2B partial agonist. | ||
M7707 | CX546 | GluR |
CX-546; GR-87 | ||
CX546 is a selective positive AMPA glutamate receptor modulator. | ||
M9496 | Balaglitazone | PPAR |
DRF-2593; NN-2344; NNC-610645 | ||
Balaglitazone is an agonist of peroxisome proliferator-activated receptor (PPAR) γ, with an EC50 of 1.351 μM for human PPARγ. | ||
M9976 | D-Galactose | Animal Modeling |
D-(+)-Galactose | ||
D-Galactose is a natural aldohexose and C-4 epimer of glucose, it accelerates the aging of invertebrates and mammals and is used as a model of aging. | ||
M21075 | PF-06939999 | PRMTs |
PRMT5-IN-3 | ||
PF-06939999 (PRMT5-IN-3) is a PRMT5 inhibitor that is synthetically lethal to tumor cells in combination with DNA damaging agents. | ||
M22306 | Etripamil | Others |
Etripamil | ||
M28166 | PKR-IN-C51 | Serine/Threonine Protease |
PKR-IN-C51(compound 51) is an ATP-competitive double-stranded RNA-activated protein kinase (PKR) inhibitor with an IC50 of 9 μM. PKR-IN-C51 inhibits intracellular PKR activation in a dose-dependent manner in primary mouse macrophages. | ||
M42086 | PROTAC EGFR degrader 8 | EGFR/HER2 |
PROTAC EGFR degrader 8 (T-184) is a PROTAC EGFR degrader. | ||
M55837 | BPH-715 | Parasite |
BPH-715 is a bisphosphonate, inhibits Plasmodium liver-stage growth, with an IC50 of 10 μM for Plasmodium exoerythrocytic forms in HepG2 cells. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.